September 01, 2026 09:06 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
CJP calls off Sept 5 Delhi march after Supreme Court quashes FIRs against protesters | ‘Dismantle entire terror ecosystem’: Modi’s strong message at SCO Summit in Shehbaz’s presence | Modi’s big appeal after 7.8% GDP growth: ‘Don’t travel abroad, avoid destination weddings’ | Modi-Pezeshkian talks: Iran seeks India’s 'extensive contacts' to end West Asia war | Indus Waters Treaty row: India rejects Hague court order, says ‘no jurisdiction’ over its sovereign decisions | India beats the odds with 7.8% GDP growth; PM Modi has a message for critics | PM Modi meets Iranian President Masoud Pezeshkian during SCO summit in Kyrgyzstan | ‘Islam superior to all religions’: Karnataka minister’s remark sparks BJP-Congress war; resignation demand grows | PM Modi meets Iran's President Masoud Pezeshkian during SCO summit in Kyrgyzstan | VHP breaks silence on Durga Puja ‘guidelines’: No blanket non-veg ban, clarifies stand on theme pandals amid backlash
Stock Market
Representational Photo: ChatGPT

Market update: Sensex tumbles 120 points, Nifty below 25,850 at closing bell

| @indiablooms | Dec 17, 2025, at 04:00 pm

Mumbai/IBNS: The Indian stock market ended Wednesday on a negative note, with BSE Sensex falling 120 points and NSE Nifty 50 closing below 25,850. Sensex settled at 84,559.65, while Nifty finished at 25,818.55.

Among sector movers, HDFC Bank, ICICI Bank, Asian Paints, and Titan were top losers, while shares of Maruti, TCS, Tata Steel, Reliance, and Bharti Airtel witnessed gains.

The Indian rupee, which opened at a fresh low, rebounded to settle at ₹90.38 against the US dollar, marking a 0.7% gain—the biggest single-day rise since October 15.

Meanwhile, dialysis service provider Nephrocare Health Services made a strong stock market debut, listing at a premium of about 7%. The shares debuted at ₹491.70 on the BSE (6.8% premium) and ₹490 on the NSE (6.52% premium), according to CNBC-TV18.

Nephrocare’s ₹871.05-crore initial public offering (IPO), open for subscription from December 10–12, was oversubscribed 13.96 times, highlighting strong investor demand.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.